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ABSTRACT 
 
Supercritical fluid technology is the most innovative method to recover bioactive compounds for use as 
supplements for functional foods. Particularly, the recovery of antioxidant compounds from different herbs is 
being a matter of continuous research and development. Besides their role as food stabilizers, antioxidants can 
protect cells against the effects of free radicals and thus, play an important role in heart disease, cancer and other 
diseases. 
Rosemary (Rosmarinus officinalis L.) has been recognized as one of the Lamiaceae plant with large antioxidant 
activity. Main substances associated with the antioxidant activity are the phenolic diterpenes such as carnosol, 
rosmanol, carnosic acid, methyl carnosate, and phenolic acids such as the rosmarinic and caffeic acids. 
Particularly, carnosic acid is accepted as the most abundant antioxidant present in rosemary.  
In this work, supercritical fluid technology was applied to produce rosemary extracts with different composition 
(phenolic compounds and volatile oil content) and thus, with different antioxidant power. For this purpose, pure 
CO2 and CO2 modified with ethanol were utilized as supercritical solvents, and diverse extraction conditions 
(temperature, pressure, amount of cosolvent and fractionation procedure) were applied.  
Selected extracts, from the variety of samples obtained, were used to study the capability of rosemary 
supercritical extracts to inhibit the proliferation of human liver carcinoma cells. Moreover, the cytostatic effect 
of the different selected extracts were determined, revealing a dose-dependent effect of the different 
compositions of the extracts on the response of human hepatocarcinoma cells to the potential antitumoral effect 
of rosemary. 
 
 
INTRODUCTION 
 
Recent studies reveal that the extracts of many plants and herbs are potential anticancer drugs owing to their 
capacity to prevent, reverse and/or inhibit certain processes of carcinogenesis before the development of invasive 
cancer [1, 2]. This effect has been attributed to certain substances present in the vegetal matter; scientific studies 
are currently under development to prove that these substances possess specific functional activities.  
Rosemary (Rosmarinus officinalis L.) extracts have been reported to have several and important biological 
properties, such as hepatoprotective [3], antidiabetic [4], antioxidant [5], antiproliferative [6], antiviral [5], 
antimicrobial [7], antinociceptive [8] and antidepressant [9], among others. Some of these activities point to a 
promising beneficial effect of rosemary in controlling cancer development. Accordingly, it has been previously 
reported that rosemary extracts and their components show inhibitory effects on the growth of breast, liver, 
prostate, lung and leukemia cancer cells [10] and represses the initiation and promotion of tumorigenesis of 
melanoma and glioma in animal models [11,12,13].  
One of the most appreciated property of rosemary extract is its antioxidant capacity, which is related to the 
presence of antioxidant phenolic substances, such as carnosol, rosmanol, carnosic acid, methyl carnosate, 
rosmarinic and caffeic acids [14, 15, 16] 
Different authors [17, 18] compared rosemary extracts produced by supercritical fluid extraction (SFE) with 
those obtained using liquid solvents (ethanol and hexane) or hydro-distillation, and demonstrated the superior 
antioxidant activity of the supercritical extracts.  
 The SFE of rosemary leaves to produce natural antioxidant products has been extensively studied and reported; 
the reader is referred to some of the abundant literature available at this respect [19, 9, 20, 21, 22]. To increase 
the concentration of phenolic compounds and get more antioxidant power, fractionation of the supercritical 
extract has been proposed. In general, fractionation was accomplished by applying different conditions in two 
time sequential extractions (multi-step fractionation) or by producing a cascade decompression of the extract in 
two or more separator vessels (on-line fractionation).  
For example, on-line fractionation in a two-step depressurization system was studied by Cavero et al. [18] using 
pure CO2 and CO2 with ethanol cosolvent to increase the solubility of polar substances; the antioxidant fraction 
was isolated in the first separator, while the volatile oil was recovered in the second separator. Multi-step 
fractionation approach was employed by Ibañez et al. [23] to extract the volatile oil in a first setp (10 MPa and 
313 K) while the antioxidant fraction was obtained in a second step (40 MPa and 323 K) without using a 
cosolvent. Ivanovic et al., [24] employed similar multi-step fractionation scheme to isolate an antioxidant 
fraction from rosemary.  
In this work, rosemary supercritical extracts with different concentration of antioxidant compounds were 
produced, by using diverse extraction conditions such as temperature, pressure, amount of co-solvent (ethanol) 
and fractionation procedures. The antioxidant power of the different samples produced was evaluated by the 
DPPH test, and some selected supercritical rosemary extracts were employed to study the antitumor activity of 
the extracts when added to liver cancer cells. 
 
 
 MATERIALS AND METHODS 
 
Chemicals and samples 
2, 2- Diphenil-1-pycril hydrazyl hydrate (DPPH, 95% purity), Camphor (>97%), Bornyl acetate (95%) and 
Linalool (>97%) were purchased from Sigma-Aldrich. Carnosic acid (≥96%) and Carnosol was purchased from 
Alexis Biochemical. 1,8 cineole (98%) and Borneol (>99%) were purchased from Fluka. Ethanol and phosphoric 
acid (85%) were HPLC grade from Panreac. Acetonitrile was HPLC grade from Lab Scan (Dublin, Ireland). CO2 
(N38) was supplied from Air Liquid. LO, GO and SO were purchased from a local market. 
The rosemary (Rosmarinus officinalis L.) raw material consisted of dried leaves (water content < 5 % wt) 
obtained from an herbalist’s producer (Murcia, Spain). The sample was ground in a cooled mill. Sample particle 
size was in the range of 200 and 600 µm.  
 
Supercritical extraction  
Extractions were carried out using a supercritical fluid pilot-plant (Thar Technology, Pittsburgh, PA, USA, 
model SF2000) comprising a 2 L cylinder extraction cell and two different separators (S1 and S2), each of 0.5 L 
capacity with independent control of temperature ( 2C) and pressure ( 1 bar). The extraction equipment also 
includes a recirculation system, were CO2 is condensed, pumped up to the desired extraction pressure and heated 
up to the selected extraction temperature.  
The temperature of the extraction cell and separators was maintained at 40C and CO2 flow rate was 60 g/min in 
all experimental assays. In selected assays, fractionation of the extracted material was accomplished by setting 
the pressure of the first separator (S1) to 100 bar, while the second separator (S2) was maintained at the 
recirculation system pressure (50 bar). In this case, two different samples were collected: one sample from S1 
cell and the other from S2 cell. When no fractionation of the extract was accomplished, S1 was set to the 
recirculation system pressure and thus, only one sample was recovered from S1. Extraction conditions were 
selected on the basis of previous studies reported in the literature [17, 19, 10, 21, 22, 25, 23]. The SFE assays are 
explained in detail as follows. 
In the first extraction (Ext. 1 in Table 1) the extraction pressure was set to 15 MPa and 5% (w/w) of ethanol was 
employed as cosolvent. The time of extraction was 180 minutes; no fractionation was accomplished and then 
only one sample was collected in S1 (M1 sample). Ext. 2 is identical to Ext. 1, but 10 % (w/w) of ethanol 
cosolvent was employed. In Ext. 3 no cosolvent was employed during a first step of extraction (15MPa, 60 min) 
and then 10 % w/w ethanol was used during the second step (15 MPa, 120 min). Thus, in Ext. 3 two samples 
were collected from S1 separator, corresponding to the first (M3-1 sample) and second (M3-2 sample) extraction 
steps. Ext. 4 was also accomplished in two sequential steps: first, extractor pressure was set to 300 bar during 
360 min and no fractionation of the extracted material was accomplished (M4-1 sample); then, extractor pressure 
was 150 bar and 10 % w/w ethanol as cosolvent was employed during 180 min (M4-2 sample). Finally, Ext. 5 
was carried out without ethanol, at 300 bar and fractionation of the extracted material was accomplished during 
the first 60 min. Then, extraction continued for 300 min without fractionation. Two samples were collected: one 
from S1 (M5-1 sample) and the other from S2 (M5-2). 
 Chemical analysis 
The essential oil compounds of samples were determined by GC-MS-FID using 7890A System (Agilent 
Technologies, U.S.A.), comprising a split/splitless injector, electronic pressure control, G4513A auto injector, a 
5975C triple-Axis mass spectrometer detector, and GC-MS Solution software. The column used was an Agilent 
19091S-433 capillary column, 30 m x 0.25 mm I.D. and 0.25 µm phase thickness. Helium, 99.996% was used as 
a carrier gas at a flow of 29.4 ml/min and inlet pressure of 28.823 Psi. Oven temperature programming was 60ºC 
isothermal for 4 min then increased to 106 ºC at 2.5 ºC/min and from 106ºC to 130ºC at 1ºC/min and finally 
from 130ºC to 250 ºC at 20ºC/min, this temperature was kept constant for 10 min. Sample injections (1 μl) were 
performed in split mode (1:10). Injector temperature was of 250ºC and MS ion source and interface temperatures 
were 230 and 280ºC, respectively. The mass spectrometer was used in TIC mode, and samples were scanned 
from 40 to 500 amu. Key volatile oil compounds (1,8 cineole, camphor, borneol, verbenone and linalool) were 
identified by comparison with standard mass spectra, obtained in the same conditions and compared with the 
mass spectra from library Wiley 229. A calibration curve was employed to quantify each of the key volatile oil 
compounds. GC-MS analyses were carried out by duplicate and the average standard deviation obtained was ± 
0.08%. 
The content of carnosic acid in the samples were determined using an HPLC (Varian Pro-star) equipped with a 
Microsorb-100 C18 column (Varian) of 25 cm × 4.6 mm and 5 μm particle size. The analysis is based on the 
work of Almela et al. [26]. The mobile phase consisted of acetonitrile (solvent A) and 0.1% of phosphoric acid 
in water (solvent B) applying the following gradient: 0–8 min, 23% A, 8-25 min, 75% A, 25-40 min 75% A and 
the 40-45 min 23% A . Initial conditions were gained in 5 min. The flow rate was constant at 0.7 ml/min. 
Injection volume was 20 μl and the detection was accomplished by using a diode array detection system (Varian) 
storing the signal at a wavelength of 230 and 280 nm. Samples were analyzed by HPLC in duplicate and the 
obtained average standard deviation was ± 0.13%. 
 
Antioxidant activity by the DPPH test 
The method consists in the neutralization of free radicals of DPPH by an antioxidant sample [27]. An aliquot (50 
µl) of ethanol solution containing 5-30 µg/ml of rosemary extract, was added to 1.950 µl of DPPH in ethanol 
(23.5 μg/ml) prepared daily. Reaction was completed after 3 h at room temperature and absorbance was 
measured at 517 nm in a Nanovette Du 730 UV spectrophotometer (Beckman Coulter, USA). The DPPH 
concentration in the reaction medium was calculated from a calibration curve determined by linear regression (y 
= 0.0265·x; R2 = 0.9998). Ethanol was used to adjust zero and DPPH-ethanol solution as a reference sample. The 
amount of extract necessary to decrease the initial DPPH concentration by 50% or EC50 (g/ml) was determined 
and employed to value the antioxidant power of the sample; the lower the EC50, the higher the antioxidant power  
 
Cell culture 
Human hepatoma cancer cells HepG2, obtained from American Type Culture Collection (ATCC, Manassas, VA, 
USA), were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS) (Gibco, Grand Island, NY, USA) and 1% of antibiotic-antimycotic solution (containing 10 000 
units/mL of penicillin base, 10 000 µg/mL of streptomycin base, and 25 000 ng/mL of amphotericin B; Gibco). 
The cells were maintained under standard conditions of temperature (37ºC), humidity (95%), and carbon dioxide 
(5%). 
 
Cell viability assay 
The antiproliferative activity of SFRE was measured by MTT assay. Cells in the exponential growth phase were 
placed in 24 well plates using 500 µL of cell suspension per well at a density between 1.5 x 104 and 6.0 x 104 
cells, and incubated overnight. Then, the number of viable cells in the control wells was determined by 
colorimetric assay (described below); immediately afterwards, medium from the corresponding wells was 
replaced with new culture medium (blank wells) or supplemented with different concentrations of 5-FU (Sigma), 
SFRE, or a combination of both, according to the experiment. Cell viability was determined after 48 or 72 h. In 
order to determine the number of viable cells, 50 µL of MTT solution (5 mg/mL in PBS) was added to each well 
and incubated for 3 h; subsequently, the medium was removed and 200 µL of dimethyl sulfoxide (DMSO) was 
added to lyse the cells and resuspend the formazan (the metabolic product of MTT). Quantities of formazan 
product, which are directly related to the number of viable cells, were measured at 560 nm using a scanning 
spectrophotometer microplate reader (UVM 340 Biochrom, Cambridge, UK). At least three independent 
experiments were performed in triplicate. Concentration values corresponding to cell sensitivity (IC50), growth 
inhibition (GI50) and cytostaticity (TGI) were calculated according to the NIH definitions using a logistic 
regression.  
 
 RESULTS AND DISCUSSION 
 
Supercritical rosemary extracts 
The different conditions applied in the supercritical rosemary extraction were target to produce a sample with 
high content of antioxidant substances. Table 1 shows the extraction yield, the carnosic acid content and the total 
content (% w/w) of main volatile compounds (borneol, bornyl acetate, camphor, 1,8-cineol and verbenone) of 
the supercritical rosemary extracts produced in the Ext. 1 to 5 defined before. Low amounts of carnosol (< 3 % 
w/w) were obtained in all samples. 
As can be observed from Table 1, higher carnosic acid contents were obtained when ethanol was employed as 
CO2 cosolvent (M1, M3-2 and M4-2 samples). In the case of samples M3-2 and M4-2, the low content of 
essential oil compounds determined could be attributed to the fact that, in both experiments, the plant matrix was 
previously extracted with pure CO2 and thus, essential oil substances were almost exhausted. On the other side, 
the high yield obtained in Ext. 2 (10% w/w cosolvent) supposes a high co-extraction of other substances and 
thus, the concentration of both carnosic acid and volatile oil compounds obtained in M2 sample was 
considerably reduced with respect to M1 sample, which was produced at identical extraction conditions but 
using 5% w/w cosolvent.  
As expected, due to the fractionation procedure accomplished in Ext. 5 (no cosolvent was employed), the extract 
collected in S1 (M5-1) contains higher amounts of carnosic acid and lower amounts of volatile oil compounds 
than the sample collected in S2 (M5-2).  
 
 
Table 1. Extraction yield, carnosic acid and main volatile oil compounds (% w/w) in the supercritical rosemary 
samples produced. 
 
Ext. Sample Yield (g extract / g 
rosemary leaves x 100) 
Carnosic acid content 
(% w/w) 
Main volatiles 
compounds (% w/w) 
1 M1 7.26 25.66 10.42 
2 M2 13.44 14.18 4.69 
3 M3-1 1.42 2.00 36.92 
 M3-2 3.02 28.49 4.81 
4 M4-1 4.52 10.89 12.79 
 M4-2 4.93 30.69 2.04 
5 M5-1 2.83 16.90 13.59 
 M5-2 1.53 3.12 21.70 
 
 
The rosemary supercritical samples selected to carry out the studies about their antitumor effect on liver cancer 
cells were M4-1, M5-1, M1 and M4-2. Moreover, all samples contain similar amounts ok key volatile oil 
compounds ( 12 % w/w), except M4-2 which contains a significant reduced amount of volatile oil compounds 
( 2 % w/w).  Particularly, M4-1 and M5-1 were selected since both samples were produced without using 
ethanol as cosolvent. This is an important factor to be considered to evaluate a commercial rosemary 
supercritical extract production, since evaporation of cosolvent is an expensive task to be accomplished.  
Table 2 shows the EC50 value determined for samples M4-1, M5-1, M1 and M4-2, using the DPPH test. As 
expected, the EC50 value decreased (and the antioxidant power of the samples increased) as the content of 
carnosic acid antioxidant increased.  
 
 
Table 2. EC50 values and content of carnosic acid (% w/w) of selected supercritical rosemary samples produced 
in this work. 
 
Rosemary extract EC50 value (µg/ml) 
carnosic acid         
(% w/w) 
M4-1 32.97 10.89 
M5-1 15.91 16.90 
M1 14.77 25.66 
M4-2 9.8 30.69 
   
 Effect of supercritical rosemary extracts on the proliferation of liver cancer cells 
To examine the effect of selected rosemary supercritical extracts (M4-1, M5-1, M1 and M4-2 samples) in human 
hepatoma cancer cells, cell proliferation was analyzed by MTT assay after treatment with different 
concentrations (from 0 to 120 µg/mL) of the different compositions of extracts for 48 h. As it can be observed in 
Table 4, each rosemary supercritical extract exhibited a dose-dependent effect on cell proliferation. Values 
representing cell sensitivity to the extracts (IC50), growth inhibition (GI50) and cytostaticity (TGI) were 
determined (Table 4).  
The variation of these parameters with the % w/w of carnosic acid of the sample is depicted in Figure 1. As can 
be seen in the individual graphs, a considerably reduction of the proliferative activity of the cells is observed for 
increasing amounts of carnosic acid from M4-1 to M1 samples. That is, the higher the concentration of carnosic 
acid in these samples, the lower the values of IC50, GI50 and TGI.  
However, although sample M4-2 contains higher concentration of carnosic acid than sample M1 and 
consecutively presents higher antioxidant activity, M4-2 anti-proliferative effect is not increased with respect to 
M1, resulting even lower. On the other hand, while all M4-1, M5-1 and M1 samples contain around 12 % w/w of 
volatile oil compounds, M4-2 contain only ca. 2 % w/w.  
According to the results obtained, the anti-proliferative activity of rosemary supercritical extracts on liver cancer 
cells could not be attributed exclusively to carnosic acid antioxidant content but other substances, probably 
substances comprising the volatile oil fraction, may act synergically. These results suggest that M1 might 
constitute an efficient composition to further analyze its effects as an antitumoral agent against liver cancer. 
 
 
 
Table 4. Cell sensitivity (IC50), growth inhibition (GI50) and cytostaticity (TGI) of HepG2 cells after 48 h 
treatment with the different extracts (µg/mL).  
 
M4-1 M5-1 M1 M4-2 
% carnosic acid 10.89 16.90 25.66 30.69 
IC50 110.71 ± 18.7 93.26 ± 22.1 42.16 ± 5.9 48.01 ± 3.2 
GI50 78.98 ± 15.7 55.00 ± 10.0 20.00 ± 5.0 26.50 ± 6.5 
TGI 99.18 ± 19.2 67.47 ± 12.3 28.40 ± 0.9 44.80 ± 6.0 
 
 
 
 
CONCLUSION 
 
Supercritical rosemary extracts produced intentionally with different content of antioxidants (carnosic acid) were 
investigated on their effect to inhibit the proliferation of human liver carcinoma cells. A considerably reduction 
of the proliferative activity of the cells is observed for increasing amounts of carnosic acid in the samples. 
Although the concentration of carnosic acid demonstrated to have a crucial effect on growth inhibition and 
cytostaticity, certain synergic effect with rosemary essential oil seem to be also important. Additional studies 
will be developed on this direction.  
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Figure 1. IC50 (a), GI50 (b) and TGI (c) as a function of the carnosic acid content (% w/w) of the different 
extracts tested. 
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